The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...
Eltromin (Eltrombopag) – Mechanism of Action and Therapeutic IndicationsEltromin, whose generic name is eltrombopag, is an oral thrombopoietin‑receptor agonist (TPO‑RA) widely...